Metformin modulates insulin receptor signaling in normal and cholesterol-treated human hepatoma cells (HepG2)

By Meuillet E.J.   Wiernsperger N.   Mania-Farnell B.   Hubert P.   Cremel G.  

European Journal of Pharmacology, Vol. 377, Iss. 2, 1999-07 ,pp. : 241-252

Elsevier

Access to resources Recommend Favorite

Water-soluble compounds in the herbal preparation Abana inhibit lipid biosynthesis and enhance cholesterol efflux in HepG₂ cells

By Vidyashankar Satyakumar   Godavarthi Ashok   Varma R. S.   Nandakumar Krishna S.  

Canadian Journal of Physiology and Pharmacology, Vol. 88, Iss. 4, 2010-04 ,pp. : 456-464

NRC Research Press

Access to resources Recommend Favorite

Effects of lipid-lowering drugs on reverse cholesterol transport gene expressions in peripheral blood mononuclear and HepG2 cells

By Genvigir Fabiana Dalla Vecchia   Rodrigues Alice Cristina   Cerda Alvaro   Arazi Simone Sorkin   Willrich Maria Alice Vieira   Oliveira Raquel   Hirata Mario Hiroyuki   Dorea Egidio Lima   Bernik Márcia Martins   Curi Rui   Hirata Rosario Dominguez Crespo  

Pharmacogenomics, Vol. 11, Iss. 9, 2010-09 ,pp. : 1235-1246

Future Medicine

Access to resources Recommend Favorite

GLUTATHIONE S-CONJUGATE FORMATION AND METABOLISM IN HepG2 CELLS: A CELL MODEL OF MERCAPTURIC ACID BIOSYNTHESIS

By Rebbeor James F.   Wang Wei   Clifton Dawn   Ballatori Nazzareno  

Journal of Toxicology and Environmental Health, Vol. 53, Iss. 8, 1998-04 ,pp. : 651-663

Taylor & Francis Ltd

Access to resources Recommend Favorite

A comparison of the concentration–effect relationships of PAHs on CYP1A induction in HepG2 and Mcf7 cells

By Skupinska K.   Misiewicz I.   Kasprzycka-Guttman T.  

Archives of Toxicology, Vol. 81, Iss. 3, 2007-03 ,pp. : 183-200

Springer Publishing Company

Access to resources Recommend Favorite